XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Total
Series A Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning Balance at Dec. 31, 2019 $ (4,769)   $ 2 $ 199 $ (4,970)
Beginning balance, shares at Dec. 31, 2019   3,177,744      
Beginning balance at Dec. 31, 2019   $ 10,515      
Beginning balance, shares at Dec. 31, 2019     2,108,266    
Exercise of stock options 45     45  
Exercise of stock options, shares     52,706    
Stock-based compensation 2     2  
Net loss (2,050)       (2,050)
Ending Balance at Mar. 31, 2020 (6,772)   $ 2 246 (7,020)
Ending balance, shares at Mar. 31, 2020   3,177,744      
Ending balance at Mar. 31, 2020   $ 10,515      
Ending balance, shares at Mar. 31, 2020     2,160,972    
Beginning Balance at Dec. 31, 2019 (4,769)   $ 2 199 (4,970)
Beginning balance, shares at Dec. 31, 2019   3,177,744      
Beginning balance at Dec. 31, 2019   $ 10,515      
Beginning balance, shares at Dec. 31, 2019     2,108,266    
Net loss (41,911)        
Ending Balance at Sep. 30, 2020 20,319   $ 11 67,189 (46,881)
Ending balance, shares at Sep. 30, 2020     11,216,563    
Beginning Balance at Mar. 31, 2020 (6,772)   $ 2 246 (7,020)
Beginning balance, shares at Mar. 31, 2020   3,177,744      
Beginning balance at Mar. 31, 2020   $ 10,515      
Beginning balance, shares at Mar. 31, 2020     2,160,972    
Conversion of preferred stocks into common stock 10,515   $ 3 10,512  
Conversion of preferred stocks into common stock, shares   (3,177,744)      
Conversion of preferred stocks into common stock   $ (10,515)      
Conversion of preferred stocks into common stock, shares     3,177,744    
Sale of common stock, net of issuance costs 24,016   $ 4 24,012  
Sale of common stock, net of issuance costs, shares     4,215,929    
Issuance of common stock in connection with reverse merger 31,809   $ 2 31,807  
Issuance of common stock in connection with reverse merger, shares     1,656,076    
Issuance of common stock upon vesting of restricted stock units, shares     (16,294)    
Exercise of stock options 47     47  
Exercise of stock options, shares     3,888    
Stock-based compensation 24     24  
Net loss (34,761)       (34,761)
Ending Balance at Jun. 30, 2020 24,878   $ 11 66,648 (41,781)
Ending balance, shares at Jun. 30, 2020     11,198,315    
Exercise of stock options 166     166  
Exercise of stock options, shares     18,248    
Stock-based compensation 375     375  
Net loss (5,100)       (5,100)
Ending Balance at Sep. 30, 2020 20,319   $ 11 67,189 (46,881)
Ending balance, shares at Sep. 30, 2020     11,216,563    
Beginning Balance at Dec. 31, 2020 58,980   $ 13 110,424 (51,457)
Beginning balance, shares at Dec. 31, 2020   0      
Beginning balance, shares at Dec. 31, 2020     12,830,598    
Exercise of stock options 27     27  
Exercise of stock options, shares     7,655    
Stock-based compensation 495     495  
Cashless exercise of warrants, shares     673,463    
Net loss (4,804)       (4,804)
Ending Balance at Mar. 31, 2021 54,698   $ 13 110,946 (56,261)
Ending balance, shares at Mar. 31, 2021     13,511,716    
Beginning Balance at Dec. 31, 2020 $ 58,980   $ 13 110,424 (51,457)
Beginning balance, shares at Dec. 31, 2020   0      
Beginning balance, shares at Dec. 31, 2020     12,830,598    
Exercise of stock options, shares 29,575        
Net loss $ (18,367)        
Ending Balance at Sep. 30, 2021 43,650   $ 15 113,459 (69,824)
Ending balance, shares at Sep. 30, 2021   0      
Ending balance, shares at Sep. 30, 2021     14,754,447    
Beginning Balance at Mar. 31, 2021 54,698   $ 13 110,946 (56,261)
Beginning balance, shares at Mar. 31, 2021     13,511,716    
Issuance of common stock upon vesting of restricted stock units, shares     5,000    
Exercise of stock options 15     15  
Exercise of stock options, shares     1,939    
Stock-based compensation 1,008     1,008  
Cashless exercise of warrants     $ 1 (1)  
Cashless exercise of warrants, shares     560,402    
Net loss (5,812)       (5,812)
Ending Balance at Jun. 30, 2021 49,909   $ 14 111,968 (62,073)
Ending balance, shares at Jun. 30, 2021     14,079,057    
Exercise of stock options 19     19  
Exercise of stock options, shares     19,981    
Stock-based compensation 1,473     1,473  
Cashless exercise of warrants     $ 1 (1)  
Cashless exercise of warrants, shares     655,409    
Net loss (7,751)       (7,751)
Ending Balance at Sep. 30, 2021 $ 43,650   $ 15 $ 113,459 $ (69,824)
Ending balance, shares at Sep. 30, 2021   0      
Ending balance, shares at Sep. 30, 2021     14,754,447